Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 7 of 7 entries
View as:

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT04830137 Org: User:
Start: 05/05/21 End: 12/31/26 Due: 12/31/27

Relative Bioavailability of NX-5948 Tablets Vs Capsules and the Effect of Covariates on the PK of NX-5948 Tablets

Phase: N/A Priority: Normal
NCT ID: NCT06717269 Org: User:
Start: 11/30/24 End: 03/31/25 Due: 03/31/26

A Study of DeTIL-0255 in Adults With Advanced Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT05107739 Org: User:
Start: 12/22/21 End: 05/09/23 Due: 05/09/24

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT05131022 Org: User:
Start: 04/13/22 End: 01/31/28 Due: 01/31/29

A Food-Effect, Drug-Drug Interaction, and Pharmacokinetics Study of NX-5948 in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06593457 Org: User:
Start: 08/20/24 End: 11/14/24 Due: 11/14/25

A Study of NX-1607 in Adults With Advanced Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT05107674 Org: User:
Start: 09/29/21 End: 02/28/28 Due: 02/28/29

Absolute Bioavailability, Absorption, Metabolism, Excretion, and Mass Balance Study of [14C] NX-5948

Phase: N/A Priority: Normal
NCT ID: NCT06691828 Org: User:
Start: 11/01/24 End: 12/05/24 Due: 12/05/25